Description
Description
Pegalin 75mg is a neurological medication manufactured by Shaigan Pharmaceuticals, formulated with Pregabalin as its active ingredient. This pack contains 14 capsules and represents the lowest common strength within the Pegalin range, typically prescribed as an initial dose for patients beginning treatment or for those who are particularly sensitive to medication effects. Pregabalin works by calming overactive nerve signals in the brain and body, helping reduce chronic pain caused by nerve damage while also assisting in the control of abnormal electrical activity linked to seizures. Pegalin 75mg allows doctors to introduce therapy gradually, minimizing the risk of side effects before considering dose increases if necessary.
Ingredients
The active ingredient in Pegalin 75mg is Pregabalin, present at a strength of 75mg per capsule. The formulation also includes standard pharmaceutical excipients that support capsule stability, structure, and consistent absorption in the body.
Dosage Form
Pegalin is available as an oral capsule, with each capsule containing 75mg of Pregabalin. The pack includes 14 capsules, intended for use strictly according to a physician’s prescribed dosing schedule.
Uses
Pegalin 75mg is commonly prescribed for:
- Initiating treatment for neuropathic pain caused by diabetic nerve damage or nerve injury
- Managing early-stage fibromyalgia-related pain and discomfort
- Supporting seizure control as part of a broader epilepsy treatment plan
- Relieving mild to moderate pain associated with post-herpetic neuralgia (nerve pain following shingles)
- Serving as a starting dose for patients new to Pregabalin therapy
This medication should only be used for conditions diagnosed and confirmed by a qualified physician.
How to Use
Pegalin capsules should be taken exactly as prescribed by your doctor, with dosage typically increased gradually based on response and tolerability. It can be taken with or without food, though maintaining consistent timing is recommended. Swallow the capsule whole with a glass of water; do not open, crush, or chew it. Avoid discontinuing the medication abruptly without medical guidance, as sudden withdrawal may lead to unwanted symptoms or increased seizure risk in epilepsy patients.
Side Effects
Some patients may experience side effects while taking Pegalin, including:
- Mild dizziness or drowsiness
- Blurred vision
- Slight weight gain
- Dry mouth or mild swelling in hands and feet
In rare cases, signs of an allergic reaction such as rash, facial swelling, or difficulty breathing may occur, requiring immediate medical attention.
Pregnancy & Breastfeeding
Pegalin is generally not recommended during pregnancy unless clearly necessary and advised by a physician, as Pregabalin may pose risks to fetal development. It is also advised to avoid this medication while breastfeeding unless specifically directed by a doctor. Pregnant or nursing women should consult their healthcare provider before use.
Storage Instructions
Store Pegalin capsules at room temperature, away from direct sunlight, heat, and moisture. Keep the medication in its original packaging, out of reach of children and pets. Do not use beyond the expiry date printed on the pack.
FAQs
Q: Why is the 75mg dose often used as a starting point?
This lower strength allows the body to adjust to Pregabalin gradually, reducing the likelihood of side effects before increasing to a higher dose if needed.
Q: Can the dose be increased later if needed?
Yes, but only under medical supervision based on how well symptoms respond to treatment.
Q: Can Pegalin cause drowsiness?
Yes, dizziness and drowsiness are possible side effects, so caution is advised when driving or operating machinery until you know how the medication affects you.
Q: What should I do if I miss a dose?
Take the missed dose as soon as you remember, unless it is close to your next scheduled dose — do not double the dose.
Disclaimer
Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.






Reviews
There are no reviews yet.